Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Animal model of long COVID?

A subset of individuals has prolonged disease after COVID-19, which is known as long COVID or post-acute sequelae of COVID-19 (PASC). The underlying mechanisms are poorly understood, in part owing to a lack of experimental models. Frere et al. followed hamsters for up to a month after SARS-CoV-2 infection, looking at changes in different tissues, and compared the data with influenza A virus (IAV) infection. Both viruses triggered a similar host response dominated by type I interferon and pathology mostly of the lung with limited involvement of other organs. However, at 31 days post infection, SARS-CoV-2 showed stronger peribronchiolar metaplasia in the lung and tubular atrophy in the kidney. Furthermore, SARS-CoV-2 caused persistent inflammation in the olfactory bulb and epithelium, which was not seen in IAV-infected hamsters. Similar transcriptomic changes were seen in olfactory tissues from human autopsy samples of people recovered from COVID-19. The authors conclude that hamsters could potentially be used for further mechanistic and interventional studies of long COVID.


Original article

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Ursula Hofer.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hofer, U. Animal model of long COVID?. Nat Rev Microbiol 20, 446 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing